索尔维二季度业绩承压但维持全年指引，股价已随业绩会反弹

S. Korea’s KOSPI rebounds to close 6% in red; SK Hynix drops 10%
Introduction & Market Context
Solvay presented its second quarter 2026 results on July 29, revealing a challenging period marked by geopolitical disruption and market pressures, yet maintaining confidence in its full-year outlook. The Belgian chemical company reported underlying net sales of €1.0 billion and underlying EBITDA of €187 million, both down significantly year-over-year, but emphasized sequential improvement across all business units and the temporary nature of key headwinds.
The company’s shares rose 3.92% to $27.32 following the presentation, suggesting investors focused on management’s confirmed guidance and strategic progress rather than the near-term operational challenges. The stock now trades approximately 8.5% below its 52-week high of $29.88.
Quarterly Performance Highlights
As detailed in the company’s financial summary, Solvay’s second quarter reflected pressure from multiple external factors. Underlying net sales declined 7.4% on an organic basis to €1.031 billion, while underlying EBITDA fell 19.5% organically to €187 million, representing an 18.1% margin compared to 20.9% in the prior-year quarter.
The presentation attributed the performance decline to three main factors: pricing pressure on seaborne soda ash markets, the temporary shutdown of the HPPO Peroxides plant in Saudi Arabia due to regional conflict, and a difficult comparison against a €20 million one-time benefit from a specialty chemicals contract termination in Q2 2025.
Despite these challenges, management highlighted positive developments including strong performance in bicarbonate and electronic-grade peroxides, which reached record sales levels, and a clear recovery in the Coatis business in Brazil. The company also achieved €26 million in cost savings during the quarter, bringing the first-half total to €48 million.
Detailed Financial Analysis
The company’s revenue bridge analysis reveals the specific drivers behind the 7.4% organic sales decline. Volume and mix effects reduced sales by €58 million, primarily due to the Saudi peroxides plant shutdown and the prior-year contract termination. Pricing pressure, concentrated in seaborne soda ash markets, contributed an additional €24 million headwind, though the company noted resilient pricing in other business lines.
The EBITDA waterfall chart illustrates an even steeper profitability decline, with volume and mix factors reducing EBITDA by €62 million. However, the company demonstrated operational discipline by generating €10 million in fixed cost savings that more than offset inflation, while net pricing remained roughly neutral as improved margins in Coatis offset higher costs elsewhere.
Within the Basic Chemicals segment, soda ash and derivatives reported net sales of €404 million, down 8% organically, as delayed shipments and seaborne pricing pressure offset steady performance in bicarbonate. The Peroxides business generated €218 million in sales, declining 5% organically due to the Saudi plant suspension, though electronic grades showed strong growth. The combined segment delivered €134 million in EBITDA with a 21.5% margin.
Performance Chemicals showed more varied results across its three business lines. Silica remained resilient at €130 million in sales despite an unfavorable regional mix. Coatis demonstrated clear recovery with €131 million in sales, up 10% reported and 1% organically, benefiting from improved pricing in both phenol and solvents. Special Chemicals generated €148 million in sales, with the 18% decline primarily reflecting the difficult prior-year comparison. The segment’s combined EBITDA of €78 million represented a 19.2% margin.
Cash Flow and Capital Structure
Solvay generated €15 million in free cash flow to shareholders during the first half, though the second quarter alone showed a negative €11 million due to typical seasonal working capital movements. The cash flow bridge demonstrates the various pressures on liquidity, including €141 million in capital expenditure, €79 million in working capital build consistent with seasonal patterns, and €106 million in provision payments related to ongoing restructuring projects.
The company’s net debt position increased from €1.6 billion at year-end 2025 to €1.8 billion at June 30, 2026, primarily reflecting €254 million in dividend payments to shareholders. This temporarily pushed the leverage ratio to 2.3x, though management expects a return to approximately 2.0x by year-end as cash generation improves in the second half.
Solvay maintains a BBB- credit rating from S&P with a stable outlook, alongside €0.6 billion in employee benefit liabilities and €0.5 billion in environmental liabilities. The company emphasized that transformation expenses, currently weighing on cash generation at approximately €90 million in 2026, will decline to around €50 million in 2027, providing a €40 million tailwind to future cash flow.
Strategic Initiatives
A significant portion of the presentation focused on Solvay’s rare earths capabilities, positioning this as a key growth platform. The company outlined its unique position in the value chain, performing separation, purification, and formulation at its La Rochelle, France facility and additional sites in Japan and China.
Management highlighted several strategic milestones in rare earths development. The company began producing light rare earths for permanent magnets (neodymium-praseodymium) in the first half of 2025 and became the first industrial producer of heavy rare earths for magnets (dysprosium-terbium) in Europe during 2026. Solvay has already invested €10 million in La Rochelle and plans an additional €15-20 million to develop new opportunities.
The rare earths strategy includes secured future sourcing through a letter of intent with Viridis to procure mixed rare earth concentrate from Brazil starting in 2028. Solvay emphasized its unique capability as the only company outside China with the technical expertise to separate all 17 rare earth elements, built on more than 75 years of experience. The business currently represents approximately 8% of group sales and roughly half of the Special Chemicals segment, with capacity to capture up to 30% of European demand for permanent magnets at full investment of €50-100 million.
Beyond rare earths, the company highlighted improved safety performance as evidence of operational excellence. The reportable injury rate declined to 0.26 in the second quarter with zero high-severity injuries, continuing a positive trend.
Forward-Looking Statements
Despite the challenging second quarter, Solvay confirmed its full-year 2026 guidance across all key metrics. The company expects underlying EBITDA between €770 million and €850 million, net of €40 million in transformation expenses, assuming a 1.20 EUR/USD exchange rate. Free cash flow to shareholders from continuing operations should reach a minimum of €200 million, net of €90 million in transformation expenses, while capital expenditure is projected at approximately €300 million.
Management stated that the guidance assumes the Peroxides plant in Saudi Arabia will restart before the end of the third quarter. CEO Philippe Kehren expressed confidence in this timeline, noting "We are currently actively preparing this restart for before the end of the quarter. I think we are ready to restart."
The company expects working capital to ease in the second half, with a larger reduction anticipated in the fourth quarter as activity slows seasonally. Looking to 2027, declining transformation expenses should improve cash generation by approximately €40 million as restructuring cash-outs fall from €90 million in 2026 to €50 million in 2027.
Longer term, Solvay is focusing on high-value applications including electronic-grade peroxides, rare earths for strategic materials, and portfolio optimization. The company also expressed support for recent EU emissions trading system reform proposals, stating they move in the right direction while confirming Solvay’s commitment to carbon neutrality by 2050.
Management acknowledged ongoing risks including potential prolonged Middle East disruption, continued soda ash pricing pressure from Chinese overcapacity, and execution challenges related to transformation projects. However, executives emphasized that most volume declines in the quarter stemmed from non-recurring elements, suggesting the underlying business remains fundamentally sound despite near-term headwinds.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.